Research and Expansion of Advanced Technologies, Including AI, Robotics and IoT
First written in FY2016. 32 of 36 entries say "Advanced", first in FY2017-Q3. Latest entry: 2026-08-05.
57 other companies' latest entry also says "Advanced".
- 2026-08-05AdvancedEarnings
「Taking this FTR certification as an opportunity, we will support the utilization of AI agents in customers’ cloud environments and the advancement of their entire business processes.」
The scope of generative AI utilization is being expanded to AI agents and the advancement of entire business processes. - FY2026AdvancedAnnual report
「In advanced technologies, the company has conducted multiple joint research projects with medical universities and medical institutions using deep learning in ophthalmology and other medical fields, including 9 projects during the current consolidated fiscal year. Papers for which the company’s employees were lead authors have been published in overseas journals, and the company has actively presented its research at ophthalmology and information-processing conferences.」
The company conducted 9 medical AI joint research projects during the year and expanded its output through publication in overseas journals and presentations at academic conferences. It has also broadened its research scope to applications of generative AI and large language models. - FY2026-H1RestatedAnnual report
「However, among the Group’s corporate customers, demand for upgrading existing systems remains strong and expectations for generative AI to improve productivity are rising. In particular, inquiries for digital solutions in which the Group focuses, including AI, cloud, security, and data analytics, are trending upward.」
In advanced technologies and digital solutions, the company identifies security and data analytics, in addition to AI and cloud, as priority areas and reports an upward trend in inquiries. - FY2025AdvancedAnnual report
「In July, the company established the Generative AI Business Transformation Laboratory as a virtual organization to build a foundation for the appropriate use of AI technologies across the Group and strategic initiatives aimed at future development. It aims to improve productivity and quality by continuously tracking the latest AI technology trends and applying them to its development processes.」
In addition to establishing the Generative AI Business Transformation Laboratory, the company is expanding the use of AI into research, organizational initiatives, and customer services through generative AI environment-building services, internal DX promotion support services, and research into large language models. - FY2025-H1AdvancedAnnual report
「In July, the company established the Generative AI Business Transformation Laboratory as a virtual organization to build a foundation for the appropriate use of AI technologies across the Group and strategic initiatives aimed at future development. It aims to improve productivity and quality by continuously tracking the latest AI technology trends and applying them to its development processes.」
The company established the Generative AI Business Transformation Laboratory in July to oversee the appropriate use of generative AI and its application to development processes, advancing AI adoption as an organizational initiative. - FY2024AdvancedAnnual report
「The company has conducted multiple joint research projects with medical universities and medical institutions using deep learning in ophthalmology and other medical fields, including 13 projects during the current consolidated fiscal year, and has presented the results at ophthalmology and information-processing conferences.」
The company expanded its medical AI joint research to 13 projects during the year and advanced its work through academic presentations, collaboration with medical societies and medical device industry associations, and applications including an aircraft engine internal inspection tool and dental image-processing patents. - FY2024-Q3AdvancedAnnual report
「In June, the company began providing the AI Escort service delivered by its AI specialists, and in October released RooMagic, a tool that uses mathematical optimization to improve the efficiency of hotel room assignments.」
In the AI field, the company advanced specific product commercialization by launching a service delivered by AI specialists and releasing RooMagic, a hotel room assignment optimization tool, in October. - FY2024-Q2AdvancedAnnual report
「In its digital solutions business, the company won the Revenue Growth Partner of the Year award at UiPath Japan Partner Awards 2022, presented by major RPA vendor UiPath, in April 2023.」
The company received a partner award from UiPath in the RPA field, advancing its business development and external recognition in advanced technologies. - FY2024-Q1AdvancedAnnual report
「In the AI field, the company developed CrePT, a generative AI chat service using Microsoft’s Azure OpenAI Service, to improve internal operational efficiency and enhance proposals to customers, and began operating it for employees in May 2023. In June 2023, it also began providing the AI Escort service delivered by the company’s AI specialists.」
The company made practical use of AI for internal operations and customer-facing services by launching internal operations of its generative AI chat service and beginning to provide the AI Escort service delivered by AI specialists. - FY2023AdvancedAnnual report
「In image-recognition AI and machine learning, areas of the company’s expertise, the company obtained patents in September 2022 for an information processing apparatus, information processing method, and information processing program that visualize the basis for image classification results produced by image-recognition AI. In December, it announced the development with Japan Airlines Co., Ltd. of an aircraft engine internal inspection tool using medical AI image-recognition technology.」
In image-recognition AI and machine learning, the company announced the acquisition of patents and the joint development with Japan Airlines Co., Ltd. of an aircraft engine internal inspection tool. - FY2023-Q3AdvancedAnnual report
「In image-recognition AI and machine learning, areas of the company’s expertise, the company obtained patents in September 2022 for an information processing apparatus, information processing method, and information processing program that visualize the basis for image classification results produced by image-recognition AI. In December, it announced the development with Japan Airlines Co., Ltd. of an aircraft engine internal inspection tool using medical AI image-recognition technology.」
In image-recognition AI and machine learning, business development progressed through the acquisition of patents and the announcement of joint development with Japan Airlines Co., Ltd. of a tool using medical AI. - FY2023-Q1AdvancedAnnual report
「In April, the company was certified as a UiPath Gold Partner, a certified reseller, and in May began providing e-learning for companies purchasing UiPath licenses, strengthening RPA as a digital solution.」
RPA-related development progressed with certification as a UiPath Gold Partner and the launch of e-learning for companies purchasing UiPath licenses. - FY2022-Q3AdvancedAnnual report
「October 2021: ・An employee was recognized as a UiPath Japan MVP 2021 for the second consecutive year December 2021: ・An employee won a prize in the Ophthalmology AI Contest at the 2nd General Meeting of the Japanese Ophthalmology AI Society ・Began joint research with Nagoya University on embedded security」
External recognition in the AI and RPA fields continued for a second consecutive year, while concrete progress was made in advanced technology research and external deployment through a prize in an ophthalmology AI contest and the launch of joint research with Nagoya University on embedded security. - FY2022-Q2AdvancedAnnual report
「September 2021: ・The company’s subsidiary, ㈱クリエイティブジャパン, announced the ELTRES Add-on IoT Development Kit」
In the IoT field, specific product rollout progressed with the subsidiary’s announcement of the ELTRES Add-on IoT Development Kit. - FY2022-Q1AdvancedAnnual report
「・Strengthening technology (expanding the business through new and priority technologies, including AI, cloud, and agile) May 2021: ・Certified by the Ministry of Economy, Trade and Industry as a DX Certified Business Operator ・Certified as a Microsoft Gold competency partner」
The company stated a policy of using AI, cloud, and agile technologies as priority technologies to expand its business, and progressed to external certifications as a DX Certified Business Operator and Microsoft Gold competency partner. - FY2021AdvancedAnnual report
「In advanced technologies, the company has conducted multiple joint research projects with medical universities and medical institutions using deep learning in ophthalmology and other medical fields, including 8 projects during the current consolidated fiscal year, and has presented the results at ophthalmology and information-processing conferences.」
The company conducted 8 medical AI joint research projects during the year, expanded into medical fields beyond ophthalmology, and continued activities aimed at academic presentations and practical application. - FY2021-Q3AdvancedAnnual report
「October 2020: ・An employee was recognized by UiPath as a UiPath Japan MVP 2020」
The company received external recognition in the AI and RPA fields when an employee was named a UiPath Japan MVP 2020. - FY2021-Q2RestatedAnnual report
「May 2020: ・An employee presented a paper on “Applications of AI to Medical Imaging” at a study meeting hosted by the Institute of Electronics, Information and Communication Engineers」
The company continued to report research presentations on applying AI to medical imaging, continuing its research and external communication on advanced technologies, including AI. - FY2021-Q1AdvancedAnnual report
「May 2020: ・An employee presented a paper on “Applications of AI to Medical Imaging” at a study meeting hosted by the Institute of Electronics, Information and Communication Engineers」
The company reported the presentation of research on applying AI to medical imaging as a specific research achievement. It also promoted its services and solutions through external seminars on AI and RPA. - FY2020AdvancedAnnual report
「In advanced technologies, the company has conducted multiple joint research projects with medical universities in ophthalmology using deep learning, and has registered and published or presented the results at ophthalmology conferences, artificial intelligence conferences, and international ophthalmology journals, including 2 publications during the current consolidated fiscal year. Its medical AI research has expanded beyond ophthalmology into internal medicine, gynecology, dentistry, and cardiology.」
The company expanded the scope of its medical AI research from ophthalmology to internal medicine, gynecology, dentistry, and cardiology, publishing or presenting 2 results in international journals during the year. - FY2020-Q3AdvancedAnnual report
「・NIDEK adopted the results of the company’s research and development in medical image analysis in its NAVIS(R)-EX image filing software ・The company won Partner of the Year in the AI Ecosystem Program operated by SoftBank Corp.」
The practical application and external deployment of advanced technologies progressed through adoption of the company’s medical image analysis research in products, recognition in an AI ecosystem program, a U.S. patent for machine learning, and AWS-related certifications. - FY2020-Q2AdvancedAnnual report
「July 2019: ・Obtained a U.S. patent for a method to improve the accuracy of disease classification using machine learning」
The company advanced the intellectual property protection of its advanced technologies by obtaining a U.S. patent for disease classification using machine learning. - FY2020-Q1AdvancedAnnual report
「・NIDEK adopted the results of the company’s research and development in medical image analysis in its NAVIS(R)-EX image filing software ・The company won Partner of the Year in the AI Ecosystem Program operated by SoftBank Corp.」
The practical application and external deployment of AI-related technologies progressed, with the results of medical image analysis research and development adopted in NIDEK’s software and the company receiving recognition in an AI ecosystem program. - FY2019AdvancedAnnual report
「The company successfully installed the results of its research on fundus diseases in actual equipment as its first application, and sales began in the spring.」
The company installed the results of its machine-learning research in ophthalmology equipment, leading to the start of sales. This marked concrete progress from the research stage to practical application and commercialization. - FY2019-Q3AdvancedAnnual report
「July 2018: ・Entered into a certified reseller and partner agreement for the UiPath RPA platform and began sales ・An employee gave a presentation at PMI Japan Forum 2018, hosted by the PMI Japan Chapter ・Presented the results of joint research on classifying corneal topography images using machine learning at the Institute of Electronics, Information and Communication Engineers October 2018: ・Joined UiPath’s new partner program, Training Associate ・Began offering company-hosted seminars, mainly on AI and RPA, to promote open innovation」
Following the launch of UiPath sales, the company advanced the provision and commercialization of advanced technologies through participation in a new partner program, the launch of company-hosted AI and RPA seminars, and the presentation of joint machine-learning research results. - FY2019-Q2AdvancedAnnual report
「July 2018: ・Entered into a certified reseller and partner agreement for the UiPath RPA platform and began sales ・An employee gave a presentation at PMI Japan Forum 2018, hosted by the PMI Japan Chapter ・Presented the results of joint research on classifying corneal topography images using machine learning at the Institute of Electronics, Information and Communication Engineers」
In addition to AI and machine learning, the company adopted RPA as a specific sales area, entering into a certified reseller and partner agreement for UiPath and beginning sales. It also presented the results of joint research on machine learning. - FY2019-Q1AdvancedAnnual report
「During the first quarter of the current consolidated cumulative period, the company focused on developing new businesses and services suited to market changes and accurately and swiftly adopting advanced technologies, particularly AI and RPA.」
The company has prioritized the adoption of AI and RPA and advanced its business development in these technologies, including exhibiting the Minervae series of AI solutions at Interop Tokyo 2018 in June 2018. - FY2018AdvancedAnnual report
「November 2017: ・Announced Minervae SCOPE, an artificial intelligence engine for screening eye diseases December 2017: ・Announced the development of an AI-based electronic medical record system and assistant robot for dental clinics」
In addition to announcing and developing AI-related products, the company made concrete progress in commercializing advanced technologies and establishing its delivery capabilities, including certification as an AWS APN Advanced Consulting Partner. - FY2018-Q3AdvancedAnnual report
「November 2017: ・Announced Minervae SCOPE, an artificial intelligence engine for screening eye diseases December 2017: ・Announced the development of an AI-based electronic medical record system and assistant robot for dental clinics」
AI-related product and service development progressed with the announcement of an artificial intelligence engine for screening eye diseases and the development of an AI electronic medical record system and assistant robot for dental practices. - FY2018-Q2AdvancedAnnual report
「September 2017: ・Began selling Minervae ViBOT, a chatbot that uses images」
In AI-related services, product rollout progressed with the launch of a chatbot using images, following services supporting the implementation of IBM Watson and others. - FY2018-Q1AdvancedAnnual report
「April 2017: ・Began selling Minervae PoCKET, a service supporting the implementation of IBM Watson June 2017: ・SoftBank Corp. began selling Minervae PoCKET ・Announced a call center support system integrating AI and LINE」
Specific commercialization and sales initiatives progressed, including the launch of sales of the IBM Watson implementation support service, sales by SoftBank, and the announcement of a system integrating AI and LINE. - FY2017-Q3AdvancedAnnual report
「November 2016: Presented the results of joint research with Nagoya City University at a meeting of the Medical Imaging Study Group of the Institute of Electronics, Information and Communication Engineers. Presentation topic: “Using optical coherence tomography images and machine learning to identify eye diseases.”」
The company presented the results of joint research with a university on medical imaging research using AI and machine learning at an academic conference. - FY2017-Q1RestatedAnnual report
「The Group has focused on strengthening its development capabilities, including securing and training personnel, quality management, and coordination among Group companies, in order to respond accurately and swiftly to maintaining and expanding order volumes, developing services that address market changes, and adopting advanced technologies. It has also worked to research advanced technologies, particularly AI, robotics, and IoT, create new businesses, and expand sales of various services and solutions.」
AI, robotics, and IoT remain priority areas for research and adoption. - FY2016First statedAnnual report
「Research and expansion of advanced technologies that lead digital transformation (AI, robotics, IoT)」
The company has identified the establishment of an AI and Robotics Center, development of IoT products and services, and advanced technology research as priority initiatives.